Director Amy McBride granted 3,190 RSUs at Hologic (HOLX) in Form 4 filing

Rhea-AI Filing Summary

Hologic Inc. director Amy McBride reported an acquisition of 3,190 shares of common stock in the form of restricted stock units. These units vest on the date of the 2027 Annual Meeting of Stockholders and will be settled one-for-one in common shares, bringing her direct holdings to 25,784 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wendell Amy McBride

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,190	$0.00	--

Holdings After Transaction: Common Stock — 25,784 shares (Direct)

Footnotes (1)

1. Represents restricted stock units which vest on the date of the 2027 Annual Meeting of Stockholders and are settled in shares of common stock. Restricted stock units are settled in shares of common stock on a one-for-one basis.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wendell Amy McBride

(Last) (First) (Middle)

250 CAMPUS DRIVE

(Street)

MARLBOROUGH MA 01752

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HOLOGIC INC [ HOLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A		3,190(1)	A	(2)	25,784	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units which vest on the date of the 2027 Annual Meeting of Stockholders and are settled in shares of common stock.

2. Restricted stock units are settled in shares of common stock on a one-for-one basis.

	/s/ Mark W. Irving, attorney-in-fact for Ms. Wendell	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hologic (HOLX) director Amy McBride report?

Amy McBride reported acquiring 3,190 restricted stock units of Hologic common stock. The award is a grant with no cash purchase price, reflecting equity-based compensation that increases her direct holdings to 25,784 shares following the transaction.

How many Hologic (HOLX) shares does Amy McBride hold after this Form 4 filing?

After the reported award, Amy McBride directly holds 25,784 Hologic common shares. This total includes the newly granted 3,190 restricted stock units, which will later convert into common stock on a one-for-one basis when they vest.

What type of equity did Amy McBride receive from Hologic (HOLX)?

She received 3,190 restricted stock units tied to Hologic common stock. These units represent a form of stock-based compensation and will be settled in an equivalent number of common shares once the vesting conditions tied to the 2027 Annual Meeting are met.

When do Amy McBride’s Hologic (HOLX) restricted stock units vest?

The 3,190 restricted stock units vest on the date of Hologic’s 2027 Annual Meeting of Stockholders. At that time, the units will be settled in shares of common stock on a one-for-one basis according to the grant terms.

Did Amy McBride pay a purchase price for the Hologic (HOLX) shares reported?

No cash purchase price was paid; the transaction price is reported as 0.0000 per share. The 3,190 units represent a grant or award of restricted stock units as compensation rather than an open-market stock purchase.